abrdn Healthcare Opportunities Fund (THQ) is an CEF managed by abrdn / Aberdeen. Its largest position is Merck & Co., Inc. (MRK), representing 6.96% of fund assets.
abrdn Healthcare Opportunities Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- THQ
- Type:
- CEF
- Manager:
- abrdn / Aberdeen
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 29, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
Merck & Co., Inc.
|
6.96% | $50,191,483.66 | 417,254 |
|
-
AbbVie Inc.
|
5.52% | $39,823,071.47 | 183,103 |
|
-
ABBOTT LABORATORIES
|
5.41% | $38,997,762.12 | 379,836 |
|
-
Medtronic plc
|
4.22% | $30,439,278.50 | 351,290 |
|
-
INTUITIVE SURGICAL INC
|
4.09% | $29,539,317.22 | 64,078 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
4.02% | $28,972,252.79 | 58,943 |
|
-
DANAHER CORP /DE/
|
3.97% | $28,614,811.20 | 150,922 |
|
-
ELI LILLY & Co
|
3.45% | $24,875,179.65 | 27,045 |
|
-
BRISTOL MYERS SQUIBB CO
|
3.11% | $22,412,964.90 | 369,546 |
|
-
Zoetis Inc.
|
3.10% | $22,399,967.53 | 189,493 |
|
-
Veradermics, Inc
|
3.09% | $22,285,571.85 | 352,899 |
|
-
Sarepta Therapeutics, Inc.
|
2.90% | $20,911,729.92 | 961,017 |
|
-
BIOCRYST PHARMACEUTICALS INC
|
2.59% | $18,666,168.64 | 1,960,732 |
|
-
Veradermics, Inc
|
2.39% | $17,256,432.15 | 273,261 |
|
-
BOSTON SCIENTIFIC CORP
|
2.19% | $15,828,499.25 | 252,247 |
|
-
UNIQURE NV
|
2.19% | $15,807,948.45 | 966,847 |
|
-
CVS HEALTH Corp
|
2.12% | $15,290,549.82 | 212,901 |
|
-
Oculis Holding AG
|
2.10% | $15,150,875.64 | 569,796 |
|
-
Praxis Precision Medicines, Inc.
|
2.00% | $14,423,801.92 | 44,768 |
|
-
Elevance Health, Inc.
|
1.99% | $14,323,379.25 | 48,927 |
|
-
ARS Pharmaceuticals, Inc.
|
1.99% | $14,322,532.84 | 1,783,628 |
|
-
INSULET CORP
|
1.83% | $13,190,542.40 | 62,860 |
|
-
OMEGA HEALTHCARE INVESTORS INC
|
1.81% | $13,053,495.98 | 297,889 |
|
-
GE HealthCare Technologies Inc.
|
1.60% | $11,521,194.80 | 161,860 |
|
-
WELLTOWER INC.
|
1.59% | $11,450,374.65 | 57,915 |
|
-
STATE STREET GLOBAL ADVISORS
|
1.48% | $10,691,890.95 | 10,691,891 |
|
-
Inspire Medical Systems, Inc.
|
1.45% | $10,486,626.64 | 203,308 |
|
-
BECTON DICKINSON & CO
|
1.45% | $10,485,825.93 | 66,691 |
|
-
Sabra Health Care REIT, Inc.
|
1.41% | $10,201,130.40 | 530,480 |
|
-
UNITEDHEALTH GROUP INC
|
1.39% | $10,049,983.19 | 37,141 |
|
-
Ventas, Inc.
|
1.38% | $9,922,858.08 | 121,336 |
|
-
HEALTHPEAK PROPERTIES, INC.
|
1.22% | $8,775,427.30 | 534,110 |
|
-
Vericel Corp
|
1.20% | $8,673,064.17 | 269,601 |
|
-
HUMANA INC
|
1.17% | $8,468,020.82 | 48,838 |
|
-
NEOGENOMICS INC
|
1.15% | $8,325,551.64 | 1,122,042 |
|
-
REPLIGEN CORP
|
1.15% | $8,305,720.90 | 70,495 |
|
-
MOLINA HEALTHCARE, INC.
|
1.03% | $7,401,082.60 | 55,522 |
|
-
Alignment Healthcare, Inc.
|
1.01% | $7,277,817.66 | 413,043 |
|
-
STRYKER CORP
|
1.00% | $7,190,863.56 | 21,884 |
|
-
Acadia Healthcare Company, Inc.
|
0.96% | $6,892,214.35 | 294,665 |
|
-
Abivax S.A.
|
0.93% | $6,737,677.15 | 60,509 |
|
-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
|
0.93% | $6,721,635.00 | 38,966 |
|
-
BIODESIX INC
|
0.92% | $6,647,351.00 | 458,438 |
|
-
GeneDx Holdings Corp.
|
0.83% | $5,960,643.52 | 92,816 |
|
-
Arcus Biosciences, Inc.
|
0.80% | $5,746,485.60 | 266,041 |
|
-
THIRD ARC BIO, INC
|
0.79% | $5,719,998.36 | 2,718,372 |
|
-
Disc Medicine, Inc.
|
0.76% | $5,505,681.58 | 86,107 |
|
-
ICON PLC
|
0.76% | $5,498,584.74 | 49,689 |
|
-
DEXCOM INC
|
0.76% | $5,478,420.80 | 87,236 |
|
-
IQVIA HOLDINGS INC.
|
0.73% | $5,293,902.68 | 31,042 |
Advertisement (320x50)